📋 Tender Overview
The subject of this publication is the conclusion of non-exclusive discount agreements according to § 130a Abs. 8 SGB V for medicines containing the active ingredient Testosterone (ATC code according to WHO: G03BA03), limited to the dosage form Gel (sachets) in strengths of 50 mg and 16.2 mg. The contract will be concluded within the framework of an Open-House model, meaning that the contract conclusion is open to all interested pharmaceutical companies during the participation period, provided they meet the participation requirements and accept them. It is noted that the purchase quantity is unknown, as it depends on demand and the development of the insured population, the prescribing behavior of doctors, and the dispensing and stocking behavior of public pharmacies. Minimum purchase quantities are therefore not guaranteed. Testosterone Gel (sachets), 50 mg, 16.2 mg